AGM Statement
June 12 2008 - 9:37AM
UK Regulatory
RNS Number : 5941W
Phoqus Pharmaceuticals PLC
12 June 2008
Result of AGM
West Malling, UK, 12 June 2008: Phoqus Pharmaceuticals plc (AIM: PQS) ("Phoqus" or the "Company"), the speciality pharmaceutical
company, announces that at the Annual General Meeting of earlier today, all of the resolutions were duly passed.
Enquiries:
Phoqus Pharmaceuticals Tel: 01732 870227
Suzanne Smith, Company Secretary
Nomura Code Securities Limited Tel: 020 7776 1200
Phil Walker
About Phoqus Pharmaceuticals
Phoqus Pharmaceuticals is a speciality pharmaceutical company that aims to develop differentiated products for use in high value,
specialist indications. Its first product candidate is Chronocort�, a novel physiological cortisol replacement therapy in development for
the treatment of patients with congenital adrenal hyperplasia and Addison's disease.
Further background on the Company can be found at www.phoqus.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMBXGDLUXBGGID
Phoqus (LSE:PQS)
Historical Stock Chart
From May 2024 to Jun 2024
Phoqus (LSE:PQS)
Historical Stock Chart
From Jun 2023 to Jun 2024